Autoimmunity, IgE and FcεRI-bearing cells. (October 2021)

• Record Type: Journal Article
• Authors: Charles, Nicolas
• Is Part Of: Current opinion in immunology. Volume 72(2021)
• Page Start: 43
• Page End: 50
• Publication Date: 2021-10
• Subjects: Immunology -- Periodicals; Allergy -- Periodicals; Immunology -- Abstracts -- Periodicals; Allergy -- Abstracts -- Periodicals; 616.079
• DOI: 10.1016/j.coi.2021.03.003
• Languages: English
• ISSNs: 0952-7915

Abstract

Highlights: Autoreactive IgE are described in various antibody-mediated autoimmune diseases (AAID). FcεRI-bearing cells, such as basophils or mast cells, are key players in these AAID. Anti-IgE approach may be a relevant therapeutic modality for some AAID in which it has not been investigated yet. Abstract : Antibody-mediated autoimmune diseases (AAID) involve several isotypes of autoreactive antibodies. In a growing number of AAID, autoreactive IgE are present with a significant prevalence and are often associated with the presence of IgG anti-IgE and/or anti-FcεRIα (high affinity IgE receptor α chain). FcεRI-bearing cells, such as basophils or mast cells, are key players in some of these AAID. Recent advances in the pathophysiology of these diseases led to the passed or current development of anti-IgE strategies that showed very potent effects in some of them. The present review centralizes the information on the relevance of autoreactive IgE and FcεRI-bearing cells in the pathophysiology of different AAID and the ones where the anti-IgE therapeutic strategy shows or may show some benefits for the patients.